Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the dark agouti rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 91-99

  Nielsen, C K ^a   Ross, F B ^a   Smith, M T ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; OXYCODONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMETHYLATION; DOSE RESPONSE; DRUG CROSS TOLERANCE; GLUCURONIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMAL; BENZOMORPHANS; DRUG TOLERANCE; MALE; MORPHINE; OXYCODONE; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0033810893     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats
2. Randomized, double blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain
3. The influence of pharmacogenetics on opioid analgesia: Studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model
4. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule
5. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation
6. A method for determining loss of pain sensation
7. Kappa opioids in Rhesus monkeys. III. Dependence associated with chronic administration
8. Controlled release oxycodone and morphine in cancer related pain
9. Effects of morphine metabolites on micturition in normal, unanaesthetized rats
10. Determination of oxycodone metabolites in urine and feces of several mammalian species
11. Pharmacokinetic-pharmacodynamic relationships of controlled release oxycodone
12. Intravenous morphine and oxycodone for pain after abdominal surgery
13. Peripheral morphine analgesia: Synergy with central sites and a target of morphine tolerance
14. Plasma disposition of oxycodone (OC), oxymorphone (OM), and noroxycodone (NO) with long term controlled-release (CR) oxycodone
15. The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats
16. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model
17. The disposition of morphine and its 3-and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine
18. Selective in vivo inhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism
19. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation
20. The pharmacokinetics of oxycodone after intravenous injection in adults
21. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects
22. Isolation of the major metabolites of oxycodone in humans
23. The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated
24. Morphine-3-glucuronide: Evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat
25. Morphine-3-glucuronide: A potent antagonist of morphine analgesia
26. Improved one-step solid-phase extraction method for morphine, morphine-3-glucuronide and morphine-6-glucuronide from plasma and quantitation using high-performance liquid chromatography with electrochemical detection
27. Ethylmorphine O-deethylation in isolated rat hepatocytes: Involvement of codeine O-demethylation enzyme systems